Manufacturer
SANOFI WINTHROP INDUSTRIE
Contents
Enoxaparin Na
Indication
Acute ST-elevation myocardial infarction, Unstable angina, Prophylaxis of venous thromboembolism during surgical procedures, Deep vein thrombosis, Prophylaxis of clotting in the extracorporeal circulation during haemodialysis.
Instruction
Administer via Subcutaneous Injection/IV Infusion.
Drug interaction
Increased risk of bleeding w/ anticoagulants, platelet aggregation inhibitors (e.g. dipyridamole, salicylates, NSAIDs, sulfinpyrazone). May increase bleeding w/ vit E.